MarketBeat Daily Ratings for Friday, September 27, 2024
Ratings changes for Biomea Fusion, Esperion Therapeutics, iRhythm Technologies, Summit Therapeutics, Micron Technology, Innodata, Hologic and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. September 27th, 2024 Today's Top Stories | | By Nathan Reiff | September 27, 2024 06:15 AM |
| | | By The Associated Press | September 27, 2024 07:39 AM |
| | By Chris Markoch | September 26, 2024 10:50 AM |
| | | By The Associated Press | September 27, 2024 12:13 AM |
| | By Jea Yu | September 26, 2024 10:04 AM |
|
|
Analysts' Upgrades | Biomea Fusion (NASDAQ:BMEA) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $54.00 price target on the stock. This represents a 423.3% upside from the current price of $10.32. | Certara (NASDAQ:CERT) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $16.00 price target on the stock. This represents a 33.9% upside from the current price of $11.95. | Vista Energy (NYSE:VIST) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $60.00 price target on the stock, up previously from $55.00. This represents a 29.4% upside from the current price of $46.37. | Wynn Resorts (NASDAQ:WYNN) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $104.00 price target on the stock, up previously from $97.00. This represents a 8.4% upside from the current price of $95.92. |
| View More Upgrades
|
Analysts' Downgrades | Agios Pharmaceuticals (NASDAQ:AGIO) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $56.00 price target on the stock, down previously from $60.00. This represents a 28.8% upside from the current price of $43.49. | Bumble (NASDAQ:BMBL) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $6.46. | Celldex Therapeutics (NASDAQ:CLDX) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.The current price is $32.09. | Campbell Soup (NASDAQ:CPB) was downgraded by analysts at DA Davidson from a "buy" rating to a "neutral" rating. They now have a $51.00 price target on the stock. This represents a 3.7% upside from the current price of $49.19. | Dollar General (NYSE:DG) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $73.00 price target on the stock, down previously from $91.00. This represents a 16.4% downside from the current price of $87.29. | HP (NYSE:HPQ) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $37.00 price target on the stock. This represents a 3.9% upside from the current price of $35.60. | Medpace (NASDAQ:MEDP) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $350.00 price target on the stock, down previously from $420.00. This represents a 5.6% upside from the current price of $331.49. | Summit Therapeutics (NASDAQ:SMMT) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $23.00 price target on the stock, up previously from $19.00. This represents a 7.7% upside from the current price of $21.36. | Ubisoft Entertainment (OTCMKTS:UBSFY) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "hold" rating.The current price is $2.21. | Udemy (NASDAQ:UDMY) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $7.50 price target on the stock, down previously from $10.00. This represents a 5.4% downside from the current price of $7.93. |
| View More Downgrades
|
Analysts' New Coverage | Airbnb (NASDAQ:ABNB) is now covered by analysts at Raymond James. They set a "market perform" rating and a $134.00 price target on the stock. This represents a 3.0% upside from the current price of $130.09. | Achieve Life Sciences (NASDAQ:ACHV) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $20.00 price target on the stock. This represents a 315.8% upside from the current price of $4.81. | ACV Auctions (NASDAQ:ACVA) is now covered by analysts at Raymond James. They set a "market perform" rating and a $22.00 price target on the stock. This represents a 6.7% upside from the current price of $20.61. | Autodesk (NASDAQ:ADSK) is now covered by analysts at DA Davidson. They set a "neutral" rating and a $260.00 price target on the stock. This represents a 4.7% downside from the current price of $272.79. | Amgen (NASDAQ:AMGN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $405.00 price target on the stock. This represents a 25.8% upside from the current price of $322.01. | Archrock (NYSE:AROC) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $24.00 price target on the stock. This represents a 17.4% upside from the current price of $20.45. | CAVA Group (NYSE:CAVA) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $135.00 price target on the stock. This represents a 9.7% upside from the current price of $123.01. | Chesapeake Energy (NASDAQ:CHK) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $92.00 price target on the stock. This represents a 11.0% upside from the current price of $82.91. | CME Group (NASDAQ:CME) is now covered by analysts at Royal Bank of Canada. They set a "sector perform" rating and a $235.00 price target on the stock. This represents a 7.1% upside from the current price of $219.38. | Dell Technologies (NYSE:DELL) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $144.00 price target on the stock. This represents a 17.6% upside from the current price of $122.45. | Intercontinental Exchange (NYSE:ICE) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $200.00 price target on the stock. This represents a 26.2% upside from the current price of $158.51. | INmune Bio (NASDAQ:INMB) is now covered by analysts at Raymond James. They set an "outperform" rating and a $18.00 price target on the stock. This represents a 246.2% upside from the current price of $5.20. | Itron (NASDAQ:ITRI) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating and a $131.00 price target on the stock. This represents a 25.7% upside from the current price of $104.23. | Kodiak Gas Services (NYSE:KGS) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $35.00 price target on the stock. This represents a 20.7% upside from the current price of $28.99. | LENZ Therapeutics (NASDAQ:LENZ) is now covered by analysts at Raymond James. They set an "outperform" rating and a $37.00 price target on the stock. This represents a 61.9% upside from the current price of $22.86. | MercadoLibre (NASDAQ:MELI) is now covered by analysts at Raymond James. They set an "outperform" rating and a $2,350.00 price target on the stock. This represents a 13.0% upside from the current price of $2,080.46. | Nasdaq (NASDAQ:NDAQ) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $88.00 price target on the stock. This represents a 21.3% upside from the current price of $72.52. | Planet Fitness (NYSE:PLNT) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $71.00 price target on the stock. This represents a 12.4% downside from the current price of $81.09. | USA Compression Partners (NYSE:USAC) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $23.00 price target on the stock. This represents a 1.8% upside from the current price of $22.59. | VersaBank (NASDAQ:VBNK) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $18.00 price target on the stock. This represents a 36.8% upside from the current price of $13.16. | VF (NYSE:VFC) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating and a $20.00 price target on the stock. This represents a 1.5% upside from the current price of $19.71. | Wave Life Sciences (NASDAQ:WVE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $13.00 price target on the stock. This represents a 56.8% upside from the current price of $8.29. |
| View More New Coverage
|
Calendars from MarketBeat | |
|
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. | Start Your 30-Day Free Trial |
| Upgrade Your Subscription | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | Upgrade Now |
|
| Manage Your Watchlist | View and add up to five holdings to your watchlist. | View My Portfolio |
|
| Join Our Facebook Group | Join MarketBeat’s free stock discussion and trading idea group on Facebook. | Join Now |
| Thank you for subscribing to MarketBeat!We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at [email protected]. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States. Today's Bonus Content: I spent 44 years on Wall Street. If you knew what I know, you’d be terrified too. |